147 related articles for article (PubMed ID: 25003235)
21. Late dissemination via cerebrospinal fluid of papillary tumor of the pineal region: a case report and literature review.
Nowicka E; Bobek-Billewicz B; Szymaś J; Tarnawski R
Folia Neuropathol; 2016; 54(1):72-9. PubMed ID: 27179224
[TBL] [Abstract][Full Text] [Related]
22. Integrated Genomic Characterization of a Pineal Parenchymal Tumor of Intermediate Differentiation.
Kang YJ; Bi WL; Dubuc AM; Martineau L; Ligon AH; Berkowitz AL; Aizer AA; Lee EQ; Ligon KL; Ramkissoon SH; Dunn IF
World Neurosurg; 2016 Jan; 85():96-105. PubMed ID: 26226092
[TBL] [Abstract][Full Text] [Related]
23. Histopathology of tumors of the pineal region.
Fèvre-Montange M; Vasiljevic A; Champier J; Jouvet A
Future Oncol; 2010 May; 6(5):791-809. PubMed ID: 20465391
[TBL] [Abstract][Full Text] [Related]
24. Papillary tumor in pineal region: Immunohistochemistry meeting the diagnostic challenge.
Dogra S; Gupta P; Malhotra P; Bhardwaj M
Indian J Pathol Microbiol; 2020; 63(1):100-102. PubMed ID: 32031133
[TBL] [Abstract][Full Text] [Related]
25. PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers.
Jin G; Kim MJ; Jeon HS; Choi JE; Kim DS; Lee EB; Cha SI; Yoon GS; Kim CH; Jung TH; Park JY
Lung Cancer; 2010 Sep; 69(3):279-83. PubMed ID: 20018398
[TBL] [Abstract][Full Text] [Related]
26. Papillary tumour of the pineal region.
Poulgrain K; Gurgo R; Winter C; Ong B; Lau Q
J Clin Neurosci; 2011 Aug; 18(8):1007-17. PubMed ID: 21658955
[TBL] [Abstract][Full Text] [Related]
27. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203
[TBL] [Abstract][Full Text] [Related]
28. PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer.
Sircar K; Yoshimoto M; Monzon FA; Koumakpayi IH; Katz RL; Khanna A; Alvarez K; Chen G; Darnel AD; Aprikian AG; Saad F; Bismar TA; Squire JA
J Pathol; 2009 Aug; 218(4):505-13. PubMed ID: 19402094
[TBL] [Abstract][Full Text] [Related]
29. Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women.
Deng L; Chen J; Zhong XR; Luo T; Wang YP; Huang HF; Yin LJ; Qiu Y; Bu H; Lv Q; Zheng H
PLoS One; 2015; 10(3):e0120511. PubMed ID: 25816324
[TBL] [Abstract][Full Text] [Related]
30. Expression and alterations of the PTEN / AKT / mTOR pathway in ameloblastomas.
Scheper MA; Chaisuparat R; Nikitakis NG; Sauk JJ
Oral Dis; 2008 Sep; 14(6):561-8. PubMed ID: 18826385
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of PTEN expression in psoriatic lesions.
Li Y; Man X; You L; Xiang Q; Li H; Xu B; Chen Z; Zhang X; Lian S
Int J Dermatol; 2014 Jul; 53(7):855-60. PubMed ID: 24168180
[TBL] [Abstract][Full Text] [Related]
32. PTEN, more than the AKT pathway.
Blanco-Aparicio C; Renner O; Leal JF; Carnero A
Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
[TBL] [Abstract][Full Text] [Related]
33. Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid tumors.
Hou P; Ji M; Xing M
Cancer; 2008 Nov; 113(9):2440-7. PubMed ID: 18831514
[TBL] [Abstract][Full Text] [Related]
34. Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.
Tokunaga E; Oki E; Kimura Y; Yamanaka T; Egashira A; Nishida K; Koga T; Morita M; Kakeji Y; Maehara Y
Breast Cancer Res Treat; 2007 Mar; 101(3):249-57. PubMed ID: 17006756
[TBL] [Abstract][Full Text] [Related]
35. Cellular pleomorphism in papillary tumors of the pineal region.
Magalhães J; Rostad S; Foltz G; Pytel P; Rodriguez FJ
Brain Tumor Pathol; 2013 Apr; 30(2):93-8. PubMed ID: 22622671
[TBL] [Abstract][Full Text] [Related]
36. Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations.
Pfaff E; Aichmüller C; Sill M; Stichel D; Snuderl M; Karajannis MA; Schuhmann MU; Schittenhelm J; Hasselblatt M; Thomas C; Korshunov A; Rhizova M; Wittmann A; Kaufhold A; Iskar M; Ketteler P; Lohmann D; Orr BA; Ellison DW; von Hoff K; Mynarek M; Rutkowski S; Sahm F; von Deimling A; Lichter P; Kool M; Zapatka M; Pfister SM; Jones DTW
Acta Neuropathol; 2020 Feb; 139(2):243-257. PubMed ID: 31768671
[TBL] [Abstract][Full Text] [Related]
37. A comprehensive analysis of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) loss in colorectal cancer.
Lin PC; Lin JK; Lin HH; Lan YT; Lin CC; Yang SH; Chen WS; Liang WY; Jiang JK; Chang SC
World J Surg Oncol; 2015 May; 13():186. PubMed ID: 25986931
[TBL] [Abstract][Full Text] [Related]
38. Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias.
Schick V; Majores M; Engels G; Spitoni S; Koch A; Elger CE; Simon M; Knobbe C; Blümcke I; Becker AJ
Acta Neuropathol; 2006 Dec; 112(6):715-25. PubMed ID: 17013611
[TBL] [Abstract][Full Text] [Related]
39. Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.
Steelman LS; Abrams SL; Whelan J; Bertrand FE; Ludwig DE; Bäsecke J; Libra M; Stivala F; Milella M; Tafuri A; Lunghi P; Bonati A; Martelli AM; McCubrey JA
Leukemia; 2008 Apr; 22(4):686-707. PubMed ID: 18337767
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological features from long-term observation of a papillary tumor of the pineal region (PTPR): a case report.
Yano H; Ohe N; Nakayama N; Shinoda J; Iwama T
Brain Tumor Pathol; 2009; 26(2):83-8. PubMed ID: 19856220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
